Citation

Ann Le Monte, Mitchell (Mitch) Goldman, M.D., Melinda L. Smedema, Patricia A. Connolly, M.S., David S. McKinsey, M.D., Gretchen Cloud, M.S., Carol Kauffman, M.D., L. Joseph Wheat, M.D. DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS. Medical Mycology. 2001 Apr 01; 39(2):207-13.

Citation

Hernan Valdez, M.D., Tanvir K. Chowdhry, Robert Asaad, M.D., Ian Woolley, M.D., Traci L. Davis, B.S.N., R.N., Robin Davidson, Nele K. Beinker, Barbara Gripshover, M.D., Robert A. Salata, M.D., Grace McComsey, M.D., Sharon Weissman, M.D., Michael M. Lederman, M.D. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999. Clinical Infectious Diseases. 2001 May 15; 32(10):1487-93.

Citation

Robert Shafer, M.D., Kurt Hertogs, Ph.D., Andrew R. Zolopa, M.D., Ann Warford, Ph.D., Stuart Bloor, Bradley J. Betts, Thomas C. Merigan, Jr., M.D., Richard Harrigan, Brendan Larder, Ph.D. High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. Journal of Clinical Microbiology. 2001 Apr 01; 39(4):1522-9.

Citation

A. Rotnitzky, D. Scharfstein, T. L. Su, J. Robins. Methods for conducting sensitivity analysis of trials with potentially nonignorable competing causes of censoring. Biometrics. 2001 Mar 01; 57(1):103-13.

Citation

Robert W. Coombs, M.D., Ph.D., David Wright, Ph.D., Patricia Reichelderfer, Ph.D., David Burns, M.D., M.P.H., Jonathan Cohn, M.D., Susan Cu-Uvin, M.D., Penny Baron, M.S., Morty Cohen, B.S., R.Ph., Alan Landay, Ph.D., S. Lewis, Andrea Kovacs, M.D. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. Journal of Infectious Diseases. 2001 Nov 01; 184(9):1187-91.

Citation

Jing Lu, M.S., Jean-Michel Gries, Davide Verotta, Ph.D., Lewis Sheiner, M.D. Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance. Journal of Pharmacokinetics & Pharmacodynamics (prev. Journal of Pharmacokinetics and Biopharmaceutics). 2001 Aug 01; 28(4):343-62.

Citation

William Borkowsky, M.D., Diane W. Wara, M.D., Terence Fenton, Ed.D., James McNamara, M.D., Minhee Kang, M.S., Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Elizabeth (Betsy) J. McFarland, M.D., Coleen K. Cunningham, M.D., Anne-Marie Duliege, M.D., M.S., Donald P. Francis, M.D., D.Sc., Yvonne J. Bryson, M.D., Sandra K. Burchett, M.D., M.S., Stephen A. Spector, M.D., Lisa M. Frenkel, M.D., Stuart E. Starr, M.D., Russell B. Van Dyke, M.D., Eleanor Jimenez, M.D., F.A.A.P. Lymphoproliferative Responses To Recombinant HIV-1 Envelope Antigens In Neonates and Infants Receiving GP 120 Vaccines. Journal of Infectious Diseases. 2000 Mar 20; 181(3):890-6.

Citation

Kenneth McIntosh, M.D., Marc Bulterys, M.D., Ph.D., Sandra K. Burchett, M.D., M.S., Mary Culnane, C.R.N.P., M.S., Bethann Cunningham-Schrader, B.A., M.S., Ken Dominguez, M.D., Lisa M. Dunkle, M.D., Linda Draper (Marillo), B.A., Linda Draper (Marillo), B.A., Mary Glenn Fowler, M.D., M.P.H., I. Celine Hanson, M.D., E. Kpamegan, Mary Lou Lindegren, J. Louise Martin-Carpenter, M.S., James McNamara, M.D., George D. McSherry, M.D., Wendy G Mitchell, M.D., Lynne M. Mofenson, M.D., F.A.A.P., James M. Oleske, M.D., P. H. Rhodes, David E. Shapiro, Ph.D., Elizabeth (Betsy) Smith, M.D., B. Styrt. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. Journal of Acquired Immune Deficiency Syndromes. 2000 Aug 27; 25:261-268.

Citation

Janet Holbrook, M.S., Marilyn Davis, R.N., M.S., Larry Hubbard, Barbara K. Martin, Ph.D., Gary Norman Holland, M.D., Douglas Jabs, M.D., M.B.A., Adele Gilpin, Curtis Meinert, M.D., Daniel S. Reshef. Studies of Ocular Complications of AIDS Research Group. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Archives of Ophthalmology. 2000 Sep 01; 118(9):1196-1204.